(C) Survival analysis of secondary recipient mice. Median survival was 62 versus 86 days posttransplant for secondary recipients of Slug +/+ or Slug -/-AML cells (5X10 5 AML GFP + cells injected), respectively (P < 0.01, Mantel-Cox test; n = 10).
(D) Complete blood count (CBC) analysis of peripheral blood in the secondary recipients injected with 5X10 4 Slug +/+ or Slug -/-AML cells at week 7 post-transplantation (n = 5).
(E) Representative peripheral blood smear stained by Wright-Giemsa (scale bar = 20 µm).
(F) Spleen morphology from the secondary recipients injected with 5X10 4 Slug +/+ or Slug -/-AML cells at week 7 post-transplantation (scale bar = 1 cm).
(G) Spleen weight from secondary recipients of Slug +/+ or Slug -/-AML cells 49 days posttransplant (n = 6).
Data are representative of two to three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance ( *P < 0.05; ** P < 0.01; N.S, no significance). (C) GFP percentage in peripheral blood at week 5 after primary BMT (n = 5).
(D) Survival analysis of primary recipient mice. Median survival was 262 versus 336 days posttransplant for primary recipients of Slug +/+ or Slug -/-AML cells, respectively (P < 0.01, Mantel-Cox test; n = 5).
Data are representative of three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance ( *P < 0.05; ** P < 0.01; N.S, no significance). (C) GFP percentage in peripheral blood at week 3 after transplantation with 1X10 5 AML cells (n = 9).
(D) Spleen weight from the recipients of at week 3 post-transplantation (n= 4).
(E) Percentage of apoptotic L-GMP cells in the BM from recipients injected with AML cells at week 3 post-transplantation (n= 4).
(F) Quantification of L-GMP in the BM from recipients at week 3 post-transplantation (n= 4). The recipient mice were injected with 1X10 5 AML cells infected by shRNA CTR, Slug shRNA #1, and Slug shRNA #2, respectively.
(G) Cell cycle phase distribution of L-GMP cells in BM from recipients injected with AML cells at week 3 post-transplantation (n= 4).
(H) Median survival was 49 versus 58 and 61 days post-transplant for recipients of 1X10 5 AML cells infected by shRNA CTR, Slug shRNA #1 and Slug shRNA #2, respectively (P < 0.01, Mantel-Cox test; n = 10).
Data are representative of two to three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance (* P < 0.05; ** P < 0.01; N.S, no significance). Figure 9 . Slc13a3 luciferase reporter assays. 293T cells were transfected with Slc13a3-Luc together with 400 ng of pMIG (vector control), or pMIG-cMyc with different dose of pMIG-Slug (100, 200, or 300 ng), then cultured for 72 h before luciferase activity assay. 50 ng of pCMV-LacZ was included in each transfection as an internal control to normalized luciferase activity (n = 3). Data are representative of two independent experiments. All data are represented as mean ± SD. Two-tailed Student's ttests were used to assess statistical significance (** P < 0.01; N.S., not significant). (B) qPCR analysis of Slc13a3 expression in MLL-AF9-driven AML cells infected with retroviral vector pMIG and pMIG-Slug, respectively (n = 3).
(C) GFP percentage in peripheral blood at week 2 after transplantation with 5X10 4 AML cells infected with retroviral vector pMIG and pMIG-Slug, respectively (n = 6).
(D) Frequency of L-GMP in the BM from primary recipients injected with 5X10 4 AML cells infected with retroviral vector pMIG and pMIG-Slug, respectively, at week 2 posttransplantation (n = 5).
(E) Flow cytometric analysis of ROS levels in L-GMPs from recipient mice injected with 5X10 4 AML cells carrying pMIG vector and pMIG-Slug, respectively. Levels of ROS were evaluated by flow cytometry. MFI, median fluorescence intensity (n = 4) Data are representative of two to three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance ((* P < 0.05; ** P < 0.01). Data are representative of two to three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance (* P < 0.05; ** P < 0.01). NB4 (B) . The cells were cultured in RPMI1640 containing 10% fetal bovine serum treated with saline, cytarabine, combination of cytarabine and TAT-control peptide, or combination of cytarabine and TAT-SNAG peptide. The cell number was counted at different time points (n = 3). Data are representative of three independent experiments. All data are represented as mean ± SD. Two-tailed Student's t-tests were used to assess statistical significance (* P < 0.05; ** P < 0.01). (A) The expression of SLUG between normal hematopoietic cells of healthy controls and AML blasts and mononuclear cells of patients. The data were obtained from a public microarray database (GSE6613, GSE1751, and GSE8970) (normal samples n = 36, AML samples n = 34).
(B) The expression of SLUG between normal BM cells of healthy controls and FAB subtypes of AML patients. The data were obtained from a public microarray database (GSE3365, GSE12417 and GSE10358) (normal patient, n = 57; M0 patient n = 17; M1 patient n = 80; M2 patient n = 89; M3 patient n = 36; M4 patient n = 87; M5 patient n = 27).
(C) The expression of SLUG between normal GMPs and AML patients' L-GMPs (normal patient, n = 9; AML patient n =16). 
